Targeting the LYPD3 signaling pathway in metastatic breast cancer
Research Grant
Administered By
Pharmacology & Cancer Biology
Awarded By
Susan G. Komen Breast Cancer Foundation
Start Date
April 1, 2018
End Date
October 31, 2026
Administered By
Pharmacology & Cancer Biology
Awarded By
Susan G. Komen Breast Cancer Foundation
Start Date
April 1, 2018
End Date
October 31, 2026